NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer |
| |
| Authors: | Klaus Sahora Irene Kuehrer Martin Schindl Claus Koelblinger Peter Goetzinger Michael Gnant |
| |
| Affiliation: | (1) Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria;(2) Department of Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria; |
| |
| Abstract: | Background About 30% of patients with pancreatic cancer suffer from locally advanced nonmetastatic carcinoma at the time of diagnosis. We conducted a prospective phase II clinical trial using neoadjuvant chemotherapy, consisting of gemcitabine and docetaxel, to assess the rate of complete radical resection and overall survival. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
